CorePharma`s Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
28 Nov 2022 //
FDA
Another Example Of A “Shkrelian” Drug Price Increase
29 Oct 2022 //
FORBES
CorePharma`s Generic Chlorzoxazone Receives Approval in the U.S.
20 Oct 2022 //
FDA
CorePharma`s Generic Clorazepate Dipotassium Receives Approval in the U.S.
14 Jun 2022 //
FDA
CorePharma to reopen under new ownership following Impax sale
31 Jan 2018 //
OUTSOURCING
CorePharma, LLC Acquired by Investor Group
30 Jan 2018 //
PR NEWSWIRE
Corepharma`s Generic Glyburide approved in US for Type 2 diabetes
30 Sep 2015 //
FDA